NCT01337518 2012-12-18A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate CancerEnzon Pharmaceuticals, Inc.Phase 1 Suspended150 enrolled